Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Hemispherx Biopharma, Inc. (HEB)

-NYSE MKT
0.24 Up 0.01(4.29%) Feb 27, 4:00PM EST
Add to Portfolio
Prev Close:0.23
Open:0.23
Bid:0.24 x 20700
Ask:0.24 x 300
1y Target Est:3.00
Beta:-0.17
Next Earnings Date:N/A
Day's Range:0.23 - 0.24
52wk Range:0.21 - 0.49
Volume:1,474,080
Avg Vol (3m):1,616,890
Market Cap:48.61M
P/E (ttm):N/A
EPS (ttm):-0.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
HEBUp 4.29%48.61M
GILDDown 0.63%154.20B
MRKDown 0.71%166.89B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):241.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :N/A
Quarterly EPS Est (Dec-14) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Hemispherx Biopharma, Inc., a specialty pharmaceutical company, is engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders in the... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback